HOPE(HOPE)
HOPE
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $624M | $771M |
| Low | $623M | $750M |
| High | $625M | $793M |
| EBITDA Avg | $152M | $188M |
| Low | $152M | $183M |
| High | $152M | $193M |
| EBIT Avg | $152M | $188M |
| Low | $151M | $182M |
| High | $152M | $193M |
| Net Income Avg | $141M | $194M |
| Low | $139M | $188M |
| High | $143M | $200M |
| EPS Avg | $1.09 | $1.52 |
| Low | $1.08 | $1.46 |
| High | $1.11 | $1.56 |
| Analysts (Rev / EPS) | 2 / 3 | 2 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $153M | $183M | $184M | $191M | $196M | $201M |
| Low | $152M | $180M | $182M | $188M | $194M | $198M |
| High | $153M | $186M | $186M | $193M | $198M | $203M |
| EBITDA Avg | $37M | $45M | $45M | $46M | $48M | $49M |
| Low | $37M | $44M | $44M | $46M | $47M | $48M |
| High | $37M | $45M | $45M | $47M | $48M | $49M |
| EBIT Avg | $37M | $45M | $45M | $46M | $48M | $49M |
| Low | $37M | $44M | $44M | $46M | $47M | $48M |
| High | $37M | $45M | $45M | $47M | $48M | $49M |
| Net Income Avg | $38M | $40M | $42M | $47M | $51M | $56M |
| Low | $35M | $38M | $41M | $46M | $50M | $55M |
| High | $39M | $43M | $43M | $47M | $51M | $57M |
| EPS Avg | $0.29 | $0.32 | $0.33 | $0.36 | $0.40 | $0.44 |
| Low | $0.28 | $0.30 | $0.32 | $0.36 | $0.39 | $0.43 |
| High | $0.30 | $0.33 | $0.33 | $0.37 | $0.40 | $0.44 |
| Analysts (Rev / EPS) | 2 / 3 | 2 / 3 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |